NovaBay Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2009

31.03.2010 | Author:admin

to $3.75 million in milestone payments from Galderma SA for the successful completion of formulation feasibility studies and an exploratory Acne study.
See all stories on this topic

Leave a Reply

You must be logged in to post a comment.